z-logo
open-access-imgOpen Access
Candida albicans drug resistance – another way to cope with stress
Author(s) -
Richard D. Can,
Erwin Lamping,
Ann R. Holmes,
Kyoko Niimi,
Koichi Tanabe,
Masakazu Niimi,
Brian C. Monk
Publication year - 2007
Publication title -
microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 179
eISSN - 1465-2080
pISSN - 1350-0872
DOI - 10.1099/mic.0.2007/010405-0
Subject(s) - candida albicans , drug , antifungal drug , drug resistance , antifungal , corpus albicans , resistance (ecology) , antifungal drugs , fungal pathogen , microbiology and biotechnology , biology , pharmacology , pathogen , ecology
There are relatively few classes of antifungal drugs. This restricts clinicians' therapeutic choices and these choices are further reduced by the emergence of drug resistance. Exposure to antifungal drugs represents an environmental stress for the fungal pathogen Candida albicans. The immediate response of C. albicans to antifungals may be drug tolerance, which can lead to drug resistance. This article examines C. albicans drug resistance from the perspective of it being a stress response and investigates how commonality with other stress-response pathways gives insights into the prospects for overcoming, or preventing, drug resistance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom